INNOVA CAPTAB - Share Price & Details
High price all time
1,260
Peer Comparison
About INNOVA CAPTAB
INNOVA CAPTAB LIMITED, with Security Code 544067, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
Quarterly Table
| Metrics | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|
| Sales | 211.7 | 236.5 | 198.1 | 226.8 | 240.2 | 248.5 | 242.5 |
|---|
| Expenses | 185.4 | 205.9 | 174.7 | 198.4 | 207.0 | 216.0 | 214.3 |
|---|
| Operating Profit | 26.3 | 30.5 | 23.4 | 28.4 | 33.2 | 32.5 | 28.2 |
|---|
| OPM % | 12.41% | 12.91% | 11.81% | 12.54% | 13.82% | 13.07% | 11.62% |
|---|
| Other Income | 2.1 | 1.8 | 6.0 | 4.6 | 4.3 | 3.5 | 4.4 |
|---|
| Interest | 5.2 | 3.8 | 0.1 | 0.1 | 0.1 | 0.1 | 1.9 |
|---|
| Depreciation | 2.8 | 3.0 | 2.9 | 3.1 | 3.1 | 3.1 | 7.8 |
|---|
| Profit before tax | 20.4 | 25.5 | 26.3 | 29.9 | 34.3 | 32.8 | 22.9 |
|---|
| Tax % | -29% | -26.9% | -25.2% | 25.4% | -25.4% | 25.5% | 25.1% |
|---|
| Net Profit | 14.5 | 18.7 | 19.7 | 22.3 | 25.6 | 24.4 | 17.1 |
|---|
| EPS in Rs | 3.02 | 3.26 | 3.45 | 3.9 | 4.48 | 4.26 | 2.99 |
|---|
| Metrics | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|
| Sales | 282.9 | 302.5 | 262.6 | 294.3 | 318.2 | 316.5 |
|---|
| Expenses | 242.5 | 257.9 | 224.6 | 252.1 | 268.5 | 269.9 |
|---|
| Operating Profit | 40.5 | 44.6 | 38.1 | 42.2 | 49.7 | 46.6 |
|---|
| OPM % | 14.31% | 14.74% | 14.5% | 14.33% | 15.63% | 14.71% |
|---|
| Other Income | 3.3 | 2.3 | 5.7 | 2.1 | 2.2 | 4.3 |
|---|
| Interest | 8.8 | 6.8 | 0.8 | 0.1 | 0.1 | 0.2 |
|---|
| Depreciation | 4.8 | 4.9 | 3.4 | 4.9 | 5.0 | 5.1 |
|---|
| Profit before tax | 30.2 | 35.2 | 39.5 | 39.3 | 46.8 | 45.6 |
|---|
| Tax % | -24.1% | -28.6% | -27.4% | -25% | 25.2% | -25% |
|---|
| Net Profit | 22.9 | 25.1 | 28.7 | 29.5 | 35.0 | 34.2 |
|---|
| EPS in Rs | 4.77 | 4.39 | 5.02 | 5.15 | 6.12 | 5.97 |
|---|
Shareholding Distribution
Shareholding Pattern
Compounded Data
| Compounded Sales
Growth |
| 10 Years: |
0% |
| 5 Years: |
21% |
| 3 Years: |
7% |
| TTM: |
11% |
| Compounded Profit
Growth |
| 10 Years: |
0% |
| 5 Years: |
26% |
| 3 Years: |
11% |
| TTM: |
29% |
| Stock Price CAGR |
| 10 Years: |
0% |
| 5 Years: |
0% |
| 3 Years: |
0% |
| 1 Year: |
75% |
| Compounded Sales
Growth |
| 10 Years: |
0% |
| 5 Years: |
27% |
| 3 Years: |
16% |
| TTM: |
15% |
| Compounded Profit
Growth |
| 10 Years: |
0% |
| 5 Years: |
36% |
| 3 Years: |
26% |
| TTM: |
36% |
| Stock Price CAGR |
| 10 Years: |
0% |
| 5 Years: |
0% |
| 3 Years: |
0% |
| 1 Year: |
75% |
